Literature DB >> 14764130

The prevalence of urinary incontinence in women in four European countries.

S Hunskaar1, G Lose, D Sykes, S Voss.   

Abstract

OBJECTIVE: To determine the prevalence, type and treatment behaviour of women with urinary incontinence in four European countries. SUBJECTS AND METHODS: Data were collected using a postal survey which was sent to 29,500 community-dwelling women aged > or = 18 years in France, Germany, Spain and the UK. Subjects were asked about the type of urinary incontinence they had experienced and their treatment behaviour.
RESULTS: Of the women who responded, 35% reported involuntary loss of urine in the preceding 30 days; stress urinary incontinence was the most prevalent type. The lowest prevalence was in Spain (23%), while the prevalence was 44%, 41% and 42% for France, Germany and the UK, respectively. About a quarter of women with urinary incontinence in Spain (24%) and the UK (25%) had consulted a doctor about it; in France (33%) and Germany (40%) the percentages were higher. Overall, <5% of the women had ever undergone surgery for their condition. While pads were used by half of the women, there were some differences among the countries.
CONCLUSIONS: Millions of women in Europe have urinary incontinence; the consultation and treatment rates were low in the European countries included in this study.

Entities:  

Mesh:

Year:  2004        PMID: 14764130     DOI: 10.1111/j.1464-410x.2003.04609.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  131 in total

1.  The greatest taboo: urinary incontinence as a source of shame and embarrassment.

Authors:  Ksenia Elenskaia; Karin Haidvogel; Christine Heidinger; Daniela Doerfler; Wolfgang Umek; Engelbert Hanzal
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

2.  One-year results of a prospective randomized, evaluator-blinded, multicenter study comparing TVT and TVT Secur.

Authors:  Maria Andrada Hamer; Per-Göran Larsson; Pia Teleman; Christina Eten Bergqvist; Jan Persson
Journal:  Int Urogynecol J       Date:  2012-06-16       Impact factor: 2.894

3.  Mixed incontinence: comparing definitions in non-surgical patients.

Authors:  Linda Brubaker; Emily S Lukacz; Kathryn Burgio; Philippe Zimmern; Peggy Norton; Wendy Leng; Harry Johnson; Stephen Kraus; Anne Stoddard
Journal:  Neurourol Urodyn       Date:  2011-01       Impact factor: 2.696

4.  Anxiety and depression associated with incontinence in middle-aged women: a large Norwegian cross-sectional study.

Authors:  Gunhild Felde; Ingvar Bjelland; Steinar Hunskaar
Journal:  Int Urogynecol J       Date:  2011-11-09       Impact factor: 2.894

Review 5.  What's a 'cure'? Patient-centred outcomes of treatments for stress urinary incontinence.

Authors:  R M Freeman
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-12

6.  Weight and urinary incontinence: the missing links.

Authors:  Stian Langeland Wesnes
Journal:  Int Urogynecol J       Date:  2013-11-28       Impact factor: 2.894

7.  Incidence and risk factors for reoperation of surgically treated urinary incontinence.

Authors:  Patrick Dällenbach; Carine Luyet; Carol Jungo Nancoz; Michel Boulvain
Journal:  Int Urogynecol J       Date:  2012-10-23       Impact factor: 2.894

8.  Measuring urinary incontinence in a population of women in northern Mexico: prevalence and severity.

Authors:  Hilda García-Pérez; Siobán D Harlow; Carolyn M Sampselle; Catalina Denman
Journal:  Int Urogynecol J       Date:  2012-10-25       Impact factor: 2.894

9.  Long-term outcome of transobturator tape (TOT) for treatment of stress urinary incontinence in females with neuropathic bladders.

Authors:  G S Losco; J R Burki; Y A I Omar; P J R Shah; R Hamid
Journal:  Spinal Cord       Date:  2015-04-28       Impact factor: 2.772

10.  The hidden epidemic of urinary incontinence in women: a population-based study with emphasis on preventive strategies.

Authors:  Batoul Ahmadi; Masoumeh Alimohammadian; Banafsheh Golestan; Bahar Mahjubi; Leila Janani; Rezvan Mirzaei
Journal:  Int Urogynecol J       Date:  2010-01-20       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.